Ardego Therapeutics, Inc.AT
SEC Form D filing

Ardego Therapeutics, Inc.

Biotech · Series A · Regulation D 506(b) · MD · Filed June 3, 2026

Offering amount
$3.0M
Exemption
Reg D 506(b)
Issuer state
MD
Filing date
June 3, 2026
Signature date
May 27, 2026
CIK
0002138133

Summary

Auto-generated

biotechnology therapeutics company, $3M Series A raise in MD

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.